Antibiotic challenges and the Melinta situation
by Robert Herriman from Outbreak News Today on (#4XK5B)
By NewsDesk @infectiousdiseasenews In late December 2019, antibiotic development and commercialization company, Melinta Therapeutics, Inc. initiated a voluntary Chapter 11 process to effectuate restructuring transaction while continuing normal-course operations. This caused a ripple effect of concern in the medical and public community. This followed just six months after Achaogen filed for bankruptcy. In this video, I ["]
The post Antibiotic challenges and the Melinta situation appeared first on Outbreak News Today.